drugset / Trial / NCT06068608
A Trial to Evaluate the Safety, Pharmacokinetics and Pharmacodynamic Profile of TNM005 in Healthy Adult Subjectsy
RandomizedParallel-groupDouble-blindPrevention
Summary
The purpose of this clinical trial is to evaluate the safety and tolerability of TNM005 following a single dose by intramuscular (IM) administration in healthy adult subjects The main questions it aims to answer are:1. safety profile；2. PK properties 3. PD properties
Timeline
- Start
- 2023-09-12
- Primary completion
- 2024-12-31
- Completion
- 2024-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | TNM005 | Unknown | — | Intramuscular |
| Comparator | VARICELLA-ZOSTER IMMUNE GLOBULIN | Protein / enzyme biologic | 625 iu | Intramuscular |